Navigation Links
Pharos Innovations Joins Partnership to Fight Chronic Disease

NORTHFIELD, Ill., Nov. 25 /PRNewswire/ -- Pharos Innovations, a pioneer in assisting clients to achieve next generation clinical and financial performance improvement through a device-free remote monitoring platform, today joined the Partnership to Fight Chronic Disease (PFCD), a coalition of leaders from the healthcare, business, policy and labor communities committed to making chronic disease the key healthcare issue in the new presidential administration.


"We are excited to be partnering with an organization that is successfully affecting change in healthcare," said Dr. Randall Williams, CEO of Pharos Innovations. "The PFCD's mission to educate the public, mobilize Americans to call for change and challenge policymakers on health policy changes is in direct alignment with our mission to transform healthcare through a new paradigm of chronic care management delivery."

Pharos joins more than 80 partner organizations in the fight against chronic disease. The PFCD is working to raise awareness of chronic disease nationwide, with a particular focus on the key primary states of Iowa, New Hampshire and South Carolina. The partnership is led by former U.S. Surgeon General Richard H. Carmona, M.D. and Ken Thorpe, PhD, chair of the Rollins School of Public Health at Emory University and a former White House health policy advisor.

"The addition of Pharos strengthens the PFCD in the fight against chronic disease," said Thorpe, executive director of the PFCD. "We look forward to tapping the Pharos team's vast knowledge and substantial resources in making chronic disease the key healthcare issue in the new presidential administration."

Chronic diseases are responsible for seven out of every 10 deaths in the U.S. -- causing more than 1.7 million American deaths every year, according to the Centers for Disease Control and Prevention (CDC). Chronic diseases are also the primary driver of healthcare costs, accounting for more than 75 percent of the $2 trillion dollars spent each year on healthcare in the U.S.

About Pharos Innovations

Founded in 1995, Pharos Innovations assists healthcare providers and payers in achieving next generation clinical and financial performance improvement. An innovative, device-free platform, Tel-Assurance(R), improves care coordination and drives dramatic clinical improvement and cost savings by remotely monitoring patients and averting unnecessary clinical events. Our enabling technologies proactively involve patients in their care and result in the early identification of clinical deterioration.

Tel-Assurance substantially expands the reach, efficiency and effectiveness of clients' current health management programs for complex chronic conditions. The Pharos solution is strongly validated to show measured clinical improvement and financial impact, is the recipient of the prestigious American Heart Association National Outcomes award and was selected for the first ever National Institutes of Health (NIH) sponsored evaluation of remote monitoring interventions. For more information visit or call (847) 790-7649.

About the PFCD

The Partnership to Fight Chronic Disease (PFCD) is a national coalition of patients, providers, community organizations, business and labor groups, and health policy experts. They are committed to raising awareness of chronic disease and the policies and practices that save lives and reduce health costs through more effective prevention and management of chronic disease.

The mission of the PFCD is to:

-- Educate the public about chronic disease and potential solutions for individuals and communities

-- Mobilize Americans to call for change in how governments, employers, and health institutions approach chronic disease

-- Challenge policymakers on the health policy changes that are necessary to effectively fight chronic disease

Currently, more than 80 advisory board members and partner organizations from across the country have joined the PFCD.

For more information on the partnership, please visit: For more information about Pharos Innovations, please contact Bonni Kaplan, senior director of marketing and communications at Pharos Innovations, at (847) 790-7649 or

     Contact:  Bonni L. Kaplan
               Pharos Innovations

SOURCE Pharos Innovations
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Inverness Medical Innovations Announces Third Quarter 2008 Results
2. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET October 29, 2008 to Discuss Third Quarter 2008 Results
3. Inverness Medical Innovations to Present at the UBS Global Life Sciences Conference on September 22, 2008
4. Inverness Medical Innovations to Attend the Goldman Sachs Diagnostics Conference on September 18, 2008
5. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
6. Inverness Medical Innovations to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008
7. Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
8. Inverness Medical Innovations to Present at Canaccord Adams 28th Annual Growth Conference on August 12, 2008
9. Atrium Innovations to Present at Upcoming 28th Annual Canaccord Adams Global Growth Conference
10. Inverness Medical Innovations Announces Second Quarter 2008 Results
11. Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008
Post Your Comments:
(Date:11/26/2015)... MUMBAI , November 26, 2015 ... --> Accutest Research ... accredited Contract Research Organization (CRO), has ... Chase Cancer Center - Temple Health ... ,     (Photo: ) ...
(Date:11/25/2015)... 25, 2015 2 nouvelles études permettent ... les différences entre les souches bactériennes retrouvées dans la ... des êtres humains . Ces recherches  ouvrent une nouvelle ... prise en charge efficace de l,un des problèmes ... chats .    --> 2 nouvelles études ...
(Date:11/25/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: AEZ) ... remain fundamentally strong and highlights the following developments: ... DSMB recommendation to continue the ZoptEC Phase 3 ... final interim efficacy and safety data , ... with heavily pretreated castration- and Taxane-resistant prostate cancer ...
(Date:11/25/2015)... San Francisco, CA (PRWEB) , ... November 25, ... ... leading microbial genomics company uBiome, were featured on AngelList early in their initial ... by launching an AngelList syndicate for individuals looking to make early stage investments ...
Breaking Biology Technology:
(Date:11/18/2015)... , November 18, 2015 ... published a new market report titled  Gesture Recognition Market ... Forecast, 2015 - 2021. According to the report, the global gesture ... is anticipated to reach US$29.1 bn by 2021, at ... North America dominated the global ...
(Date:11/16/2015)... JOSE, Calif. , Nov 16, 2015 /PRNewswire/ ... developer of human interface solutions, today announced expansion ... Synaptics TouchView ™ touch controller and display ... architectural revolution of smartphones. These new TDDI products ... include TD4100 (HD resolution), TD4302 (WQHD resolution), and ...
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
Breaking Biology News(10 mins):